Health Catalyst to Participate in Upcoming Investor Conference
Health Catalyst (Nasdaq: HCAT) announced that senior management will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference.
Rhea-AI Summary
Health Catalyst (Nasdaq: HCAT) announced that senior management will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference.
Chief Executive Officer Ben Albert will join a panel titled “AI ROI in Healthcare: Real vs Hype Debate” on June 24, 2026 at 3:30pm ET.
Positive
- None.
Negative
- None.
Details
News Market Reaction – HCAT
In the Jun 17 session, HCAT declined 0.56%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SALT LAKE CITY, June 16, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference, including a panel discussion titled “AI ROI in Healthcare: Real vs Hype Debate,” with Ben Albert, Chief Executive Officer, on Wednesday, June 24, 2026, at 3:30pm ET.
About Health Catalyst
Health Catalyst, Inc. (Nasdaq: HCAT) is a healthcare intelligence company that accelerates measurable improvement for health systems across cost, clinical, and consumer performance. Backed by deep domain expertise, proprietary AI-driven technology, and
Health Catalyst Investor Relations Contact:
Stephanie St. Clair
Finance and Investor Relations, SVP
+1 (855)-309-6800
ir@healthcatalyst.com
Health Catalyst Media Contact
Kay Blazar
VP, PR
SVM PR & Marketing
Healthcatalyst@SVMPR.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.